Cardinal Health, Inc. filed a Form 8-K on August 11, 2026, reporting that on August 7, 2026, the company entered into a new $4.0 billion unsecured revolving credit agreement and simultaneously terminated three prior credit and receivables facilities.

Key Highlights

  • New credit facility: Cardinal Health entered into an unsecured Credit Agreement providing access to $4.0 billion of revolving credit through August 7, 2031.
  • Extension option: The company may, subject to certain conditions, extend the termination date by up to two years.
  • Leverage covenant: The Credit Agreement requires the company to maintain a Consolidated Net Leverage Ratio of no greater than 4.00 to 1.00 as of the last day of any fiscal quarter.
  • Terminated facilities: Three prior facilities were terminated on August 7, 2026: a $2.0 billion five-year revolving credit facility, a $1.0 billion 364-day revolving credit facility, and a $1.0 billion committed receivables sale program.
  • No termination penalties: According to the filing, "There were no penalties incurred by the Company as a result of the terminations."
  • Administrative agent: Wells Fargo Bank, National Association serves as Administrative Agent under the new Credit Agreement.

Cardinal Health Replaces Legacy Credit Lines with Consolidated $4 Billion Facility

According to the filing, Cardinal Health, Inc. (NYSE:CAH) entered into the new unsecured Credit Agreement on August 7, 2026, with Wells Fargo Bank, National Association as Administrative Agent. Joint Lead Arrangers and Joint Bookrunners include Wells Fargo Securities, LLC, BofA Securities, Inc., Goldman Sachs Bank USA, and JPMorgan Chase Bank, N.A. The company disclosed it intends to use the revolving credit facility for general corporate purposes.

The new facility replaces three previously existing arrangements that were also terminated on August 7, 2026. These were a Five-Year Credit Agreement dated February 27, 2023, which provided $2.0 billion of revolving credit; a 364-Day Credit Agreement dated October 7, 2025, which provided $1.0 billion of revolving credit; and a receivables sale program that provided a committed facility of $1.0 billion. The filing states that no penalties were incurred in connection with those terminations.

The Credit Agreement includes customary representations, affirmative and negative covenants, and events of default, including non-payment of principal or interest and breaches of covenants, according to the filing. The single financial covenant requires the company to maintain a Consolidated Net Leverage Ratio of no greater than 4.00 to 1.00 as of the last day of any fiscal quarter, subject to certain conditions defined in the Credit Agreement. The filing also notes that the participating financial institutions or their affiliates have from time to time performed commercial banking, investment banking, and other financial advisory services for the company, for which the company pays customary fees and expenses.

What Was Disclosed

Cardinal Health disclosed the entry into a new $4.0 billion unsecured revolving credit facility maturing August 7, 2031, the termination of three prior credit and receivables facilities totaling $4.0 billion in aggregate commitments, and the financial covenant terms governing the new arrangement.